Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients

Triple Negative Breast Cancers (TNBC) subtype is an aggressive disease with poor clinical outcome. The only treatment available is surgery followed by chemotherapy or radiotherapy. Programmed death-ligand 1 (PD-L1) is a trans-membrane protein expressed on a wide variety of cells including immune cel...

詳細記述

保存先:
書誌詳細
出版年:Int J Mol Sci
主要な著者: Botti, Gerardo, Collina, Francesca, Scognamiglio, Giosuè, Rao, Federica, Peluso, Valentina, De Cecio, Rossella, Piezzo, Michela, Landi, Gabriella, De Laurentiis, Michelino, Cantile, Monica, Di Bonito, Maurizio
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2017
主題:
Communication
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5343992/
https://ncbi.nlm.nih.gov/pubmed/28230773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18020459
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料